The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: Implications for anti-vasculogenic therapy

Cancer Biology and Therapy

Volumn 1, Issue 6, 2002, Pages 661-664

  Sood, Anil K ^a   Fletcher, Mavis S ^b   Zahn, Chris M ^c   Gruman, Lynn M ^b   Coffin, Jeremy E ^b   Seftor, Elisabeth A ^b   Hendrix, Mary J C ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Ovarian cancer; Prognosis; Tumor vasculature

Indexed keywords

ARTICLE; CANCER INVASION; CANCER STAGING; CYSTADENOCARCINOMA; FEMALE; HUMAN; NECROSIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); OVARY TUMOR; PATHOLOGY; SURVIVAL RATE; VASCULARIZATION;

CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; SURVIVAL RATE;

EID: 0037636378     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.316     Document Type: Article

References (24)

1. Folkman J. Clinical applications of research on angiogenesis. Seminars in medicine of the Beth Israel Hospital, Boston. N Engl J Med 1995; 333:1757-63.
2. Sood AK, Seftor EA, Fletcher MS, Gardner LMG, Heidger PM, Buller RE, et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol 2001; 158:1279-88. (Pubitemid 32281292)
3. Breast Cancer Progression Working Party. Evidence for novel non-angiogenic pathway in breast-cancer metastasis. The Lancet 2000; 355:1787-8.
4. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Pe'er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol 1999; 155:739-52. (Pubitemid 29426820)
5. Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel MW, Kasumi F, et al. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res 2002; 62:560-6. (Pubitemid 34106432)
6. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci 97:14608-13.
7. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nature Med 2000; 6:389-95. (Pubitemid 30208155)
8. Alvarez AA, Krigman HR, Whitaker RS, Dodge RK, Rodriguez GC. The prognostic significance of angiogenesis in epithelial ovarian carcinoma. Clin Cancer Res 1999; 5:587-91. (Pubitemid 29131968)
9. Orre M, Lotfi-Miri M, Mambers P, Rogers PA. Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary. Br J Cancer 1998; 77(12):2204-9. (Pubitemid 28263942)
10. Gasparini G, Bonoldi E, Viale G, Verderio P, Borrachi P, Panizzoni GA, et al. Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J of Cancer 1996; 69(3):205-11. (Pubitemid 26233300)
11. Volm M, Koomagi R, Kaufmann M, Mattern J, Stammler G. Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas. Clin & Exp Metastasis 1996; 14(3):209-14. (Pubitemid 26246565)
12. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000; 60:1388-93. (Pubitemid 30152012)
13. Orre MR. VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary. Int J Cancer 1999; 84(2): 101-8.
14. Tímár J, Tóth J. Tumor sinuses - vascular channels. Pathol Oncol Res 2000; 6(2):83-6.
15. Warren BA, Shubik P. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Investig 1966; 15:464-78.
16. Folberg R, Hendrix MJC, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000; 156(2):361-81. (Pubitemid 30648785)
17. Hendrix MJC, Seftor REB, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, et al. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination1. Cancer Res 2002; 62:665-8. (Pubitemid 34126938)
18. Hess AR, Seftor EA, Gardner LMG, Carles-Kinch K, Schneider GB, Seftor REB, et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res 2001; 61:3250-5. (Pubitemid 32695007)
19. Hendrix MJC, Seftor EA, Meltzer PS, Gardner LMG, Hess AR, Kirschmann DA, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 2001; 98:8018-23..
20. Seftor REB, Seftor EA, Koshikawa N, Meltzer PS Gardner LMG, Bilban M, et al. Cooperative interaction of laminin 5γ2 chain, matrix metalloproteinases-2, and membrane type-1 matrix/metalloproteinases are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001; 61:6322-6327. (Pubitemid 32783230)
21. Sharma N, Seftor REB, Seftor EA, Gruman, Heidger PM, Cohen MB, et al. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. The Prostate 2002; 50:189-201. (Pubitemid 34137446)
22. Shirakawa K, Wakasugi H, Heike Y, Watanabe I, Yamada S, Saito K, et al. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 2002; 99:821-8. (Pubitemid 34575699)
23. Hendrix MJC, Seftor EA, Kirschmann DA, Seftor REB. Molecular biology of breast cancer metastasis: molecular expression of vascular markers by aggressive breast cancer cells. Breast Cancer Res 2000; 2:417-22. (Pubitemid 32223638)
24. Sood AK, Fletcher MS, Hendrix MJC. The embryonic-like properties of aggressive human tumor cells. J Soc Gynecol Investig 2002; 9(1):1-9.